Protalix BioTherapeutics (NYSE:PLX) is scheduled to announce Q4 earnings results on Monday, March 17th, before market open. The consensus EPS Estimate is $0.07 (-22.2% Y/Y) and the consensus Revenue ...

Docusign's mixed earnings report shows EPS and revenue beats but slowed growth. Click here to read an analysis of DOCU stock ...

Dell’s stock dropped post-earnings despite beating EPS estimates, as weak guidance raised concerns about future growth. Click ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

PagerDuty reported strong fiscal 2025 Q4 earnings, surpassing expectations and showcasing significant growth driven by platform innovation.

Reports Q4 revenue $33.6M vs $33.971M last year. Jeff Eberwein, Chief Executive Officer at Hudson Global (HSON), said, “Our fourth quarter ...

Duluth (NASDAQ: DLTH) Q4 2024 Earnings Call Mar 13, 2025, 9:30 a.m. ET ...

While the top- and bottom-line numbers for Crown Castle (CCI) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics ...

Ulta Beauty delivered better-than-expected earnings in their latest release, reflecting a strong quarter despite hurdles.